NEW YORK, Nov. 25, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been
filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to
request that the court appoint you as lead plaintiff.
TG Therapeutics, Inc. (NASDAQCM: TGTX)
Class Period: June 4, 2018 to September 25, 2018
Lead Plaintiff Deadline: December 3, 2018
The complaint alleges that throughout the class period TG Therapeutics, Inc. made materially false and/or
misleading statements and/or failed to disclose that: (1) TG was involved in cleaning the data collected in the UNITY-CLL Trial;
and as a result, was able to gain an understanding as to the efficacy of the combination therapy; (2) as a result of that data
cleaning, TG knew the UNITY-CLL Trial had failed to meet its stated goal and as a result, the Company would not be able to seek
accelerated approval; and (3) given that the UNITY-CLL Trial had failed to meet its stated goal, it was highly unlikely that the
combination therapy would meet its primary endpoint of increased progression free survival.
Get additional information about the TGTX lawsuit: http://www.kleinstocklaw.com/pslra-1/tg-therapeutics-inc-loss-submission-form?wire=3
Alnylam Pharmaceuticals, Inc. (NASDAQGS: ALNY)
Class Period: February 15, 2018 to September 12, 2018
Lead Plaintiff Deadline: November 26, 2018
The lawsuit alleges that Alnylam Pharmaceuticals, Inc. made materially false and/or misleading statements and/or
failed to disclose that: (1) Alnylam overstated the efficacy and safety of its Onpattro (patisiran) lipid complex injection; and
(2) as a result, Alnylam’s public statements were materially false and misleading at all relevant times.
Get additional information about the ALNY lawsuit: http://www.kleinstocklaw.com/pslra-1/alnylam-pharmaceuticals-inc-loss-submission-form?wire=3
Chegg, Inc. (NYSE: CHGG)
Class Period: July 30, 2018 to September 25, 2018
Lead Plaintiff Deadline: November 26, 2018
The complaint alleges that during the class period Chegg, Inc. made materially false and/or misleading
statements and/or failed to disclose that: (1) the Company lacked adequate security measures to protect users’ data; (2) the
Company lacked the internal controls and procedures to detect unauthorized access to its systems and to its data; (3) as a
result, the Company would incur additional expenses and litigation risks; and (4) as a result of the foregoing, Defendants’
positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a
reasonable basis.
Get additional information about the CHGG lawsuit: http://www.kleinstocklaw.com/pslra-1/chegg-inc-loss-submission-form?wire=3
Camping World Holdings, Inc. (NYSE: CWH)
Class Period: March 8, 2017 to August 7, 2018
Lead Plaintiff Deadline: December 18, 2018
Throughout the class period, Camping World Holdings, Inc. allegedly made materially false and/or misleading
statements and/or failed to disclose that: (1) the Company’s disclosure controls and controls over financial reporting suffered
from a host of material weaknesses; (2) the Company’s historical financial results had been materially misstated; (3) the Gander
stores had encountered integration setbacks, adversely impacting the Company’s earnings growth and profit margins; and (4) the
Company’s core RV business was experiencing decelerating growth as the Company lagged industry trends and was losing market share
to competitors.
Get additional information about the CWH lawsuit: http://www.kleinstocklaw.com/pslra-1/camping-world-holdings-inc-loss-submission-form?wire=3
Dycom Industries, Inc. (NYSE: DY)
Class Period: November 20, 2017 to August 10, 2018
Lead Plaintiff Deadline: December 24, 2018
During the class period, Dycom Industries, Inc. allegedly made materially false and/or misleading statements
and/or failed to disclose that: (i) Dycom’s large projects were highly dependent on permitting and tactical considerations, (ii)
Dycom was facing great uncertainties related to permitting issues; (iii) said uncertainties would expose Dycom to near-term margin
pressure and absorption issues, and (iv) as a result of the foregoing, Defendants’ statements about Dycom’s business, operations,
and prospects, were false and misleading and/or lacked a reasonable basis.
Get additional information about the DY lawsuit: http://www.kleinstocklaw.com/pslra-1/loss-submission-form-2?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or
obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J.
Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud
throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
